首页 > 最新文献

Seminarios de la Fundación Espa?ola de Reumatología最新文献

英文 中文
Artrosis erosiva de las manos 手的糜烂性骨关节炎
Pub Date : 2012-01-01 DOI: 10.1016/j.semreu.2011.10.004
Silvia Martínez Pardo, Mireia Castillo Vilella

This article provides a thorough review of erosive osteoarthritis of the hands, including the small changes observed over time in the epidemiology of the disease and the literature on genetic, etiopathogenic and clinical features. We also review the most useful complementary tests, the key points of the differential diagnosis, and end with an update on the treatment of this entity. Better understanding of this disease will help to achieve en earlier diagnosis of its signs and symptoms, a better therapeutic approach, and closer monitoring of disease progression to avoid future disability.

这篇文章提供了一个全面的审查,糜烂性骨关节炎的手,包括观察到的小变化,随着时间的推移,在疾病的流行病学和文献的遗传,致病和临床特点。我们还回顾了最有用的补充测试,鉴别诊断的关键点,并以治疗该实体的最新进展结束。更好地了解这种疾病将有助于更早地诊断其体征和症状,采用更好的治疗方法,并更密切地监测疾病进展,以避免未来致残。
{"title":"Artrosis erosiva de las manos","authors":"Silvia Martínez Pardo,&nbsp;Mireia Castillo Vilella","doi":"10.1016/j.semreu.2011.10.004","DOIUrl":"10.1016/j.semreu.2011.10.004","url":null,"abstract":"<div><p>This article provides a thorough review of erosive osteoarthritis of the hands, including the small changes observed over time in the epidemiology of the disease and the literature on genetic, etiopathogenic and clinical features. We also review the most useful complementary tests, the key points of the differential diagnosis, and end with an update on the treatment of this entity. Better understanding of this disease will help to achieve en earlier diagnosis of its signs and symptoms, a better therapeutic approach, and closer monitoring of disease progression to avoid future disability.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 1","pages":"Pages 8-14"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.10.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132521312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Miositis con cuerpos de inclusión (forma esporádica) 包涵体肌炎(散发性)
Pub Date : 2012-01-01 DOI: 10.1016/j.semreu.2011.10.003
José César Milisenda , Sergio Prieto-González , Josep Maria Grau , Grupo de Investigación en Miopatías

Sporadic inclusion body myositis (IBM) is a major subgroup among idiopathic inflammatory myopathies. The clinical and pathologic findings of this disease are well defined but are not always easy to identify. IBM mainly affects men aged more than 50 years old who usually present with chronic and sometimes asymmetrical weakness and atrophy, thus requiring a wide differential diagnosis. Some well-characterized autoimmune diseases are associated with IBM. However, unlike dermatomyositis, there is no association with neoplastic disease. Clinical and histopathological data are mandatory in the diagnosis of IBM, while laboratory and electromyographic studies are usually non-diagnostic. In contrast, magnetic resonance imaging may help in diagnosis and should possibly be included in the diagnostic criteria. The pathogenesis of IBM is still not well-defined, as it involves interrelations among inflammatory, degenerative and mitochondrial phenomena. Diagnostic delay is the rule, and the response to available treatments is poor except when an autoimmune disease is associated with IBM.

散发性包涵体肌炎(IBM)是特发性炎性肌病中的一个主要亚群。这种疾病的临床和病理表现是明确的,但并不总是容易识别。IBM主要影响50岁以上的男性,他们通常表现为慢性,有时不对称的虚弱和萎缩,因此需要广泛的鉴别诊断。一些具有明显特征的自身免疫性疾病与IBM有关。然而,与皮肌炎不同,它与肿瘤疾病无关。临床和组织病理学数据是诊断IBM的必要条件,而实验室和肌电图研究通常是非诊断性的。相反,磁共振成像可能有助于诊断,并可能包括在诊断标准。IBM的发病机制尚不明确,因为它涉及炎症、退行性和线粒体现象之间的相互关系。诊断延迟是常规,除了与IBM相关的自身免疫性疾病外,对现有治疗的反应很差。
{"title":"Miositis con cuerpos de inclusión (forma esporádica)","authors":"José César Milisenda ,&nbsp;Sergio Prieto-González ,&nbsp;Josep Maria Grau ,&nbsp;Grupo de Investigación en Miopatías","doi":"10.1016/j.semreu.2011.10.003","DOIUrl":"10.1016/j.semreu.2011.10.003","url":null,"abstract":"<div><p>Sporadic inclusion body myositis (IBM) is a major subgroup among idiopathic inflammatory myopathies. The clinical and pathologic findings of this disease are well defined but are not always easy to identify. IBM mainly affects men aged more than 50 years old who usually present with chronic and sometimes asymmetrical weakness and atrophy, thus requiring a wide differential diagnosis. Some well-characterized autoimmune diseases are associated with IBM. However, unlike dermatomyositis, there is no association with neoplastic disease. Clinical and histopathological data are mandatory in the diagnosis of IBM, while laboratory and electromyographic studies are usually non-diagnostic. In contrast, magnetic resonance imaging may help in diagnosis and should possibly be included in the diagnostic criteria. The pathogenesis of IBM is still not well-defined, as it involves interrelations among inflammatory, degenerative and mitochondrial phenomena. Diagnostic delay is the rule, and the response to available treatments is poor except when an autoimmune disease is associated with IBM.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 1","pages":"Pages 23-30"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.10.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116904207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Atrapamiento femoroacetabular Atrapamiento femoroacetabular
Pub Date : 2012-01-01 DOI: 10.1016/j.semreu.2011.10.001
Noemí Navarro, Cristóbal Orellana, Mireia Moreno, Jordi Gratacós, Marta Larrosa

Femoroacetabular impingement (FAI) is a clinical and radiological syndrome resulting from repetitive abutment between the acetabular rim and the femur. This syndrome should be included in the differential diagnosis of hip pain, especially in the young. The most important imaging technique for suspected FAI is standard radiology, but the gold-standard for diagnosis is arthro-magnetic resonance imaging (MRI). The cornerstone of treatment is surgery but outcome depends on several factors such as physical activity, FAI type, disease duration, surgical technique and, especially, whether the cartilage is damaged. For non-prosthetic surgical treatment to be effective, early diagnosis of FAI is essential. Late diagnosis, when hip osteoarthritis is already present, limits surgery to hip replacement.

股髋臼撞击(FAI)是一种临床和放射学综合征,由髋臼缘和股骨之间的重复基台引起。该综合征应包括在髋关节疼痛的鉴别诊断中,特别是在年轻人中。对疑似FAI最重要的成像技术是标准放射学,但诊断的金标准是关节磁共振成像(MRI)。治疗的基石是手术,但结果取决于几个因素,如体力活动、FAI类型、疾病持续时间、手术技术,尤其是软骨是否受损。为了使非假体手术治疗有效,早期诊断FAI至关重要。晚期诊断,当髋关节骨关节炎已经出现,限制手术髋关节置换术。
{"title":"Atrapamiento femoroacetabular","authors":"Noemí Navarro,&nbsp;Cristóbal Orellana,&nbsp;Mireia Moreno,&nbsp;Jordi Gratacós,&nbsp;Marta Larrosa","doi":"10.1016/j.semreu.2011.10.001","DOIUrl":"https://doi.org/10.1016/j.semreu.2011.10.001","url":null,"abstract":"<div><p>Femoroacetabular impingement (FAI) is a clinical and radiological syndrome resulting from repetitive abutment between the acetabular rim and the femur. This syndrome should be included in the differential diagnosis of hip pain, especially in the young. The most important imaging technique for suspected FAI is standard radiology, but the gold-standard for diagnosis is arthro-magnetic resonance imaging (MRI). The cornerstone of treatment is surgery but outcome depends on several factors such as physical activity, FAI type, disease duration, surgical technique and, especially, whether the cartilage is damaged. For non-prosthetic surgical treatment to be effective, early diagnosis of FAI is essential. Late diagnosis, when hip osteoarthritis is already present, limits surgery to hip replacement.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 1","pages":"Pages 15-22"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.10.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136937478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Síndrome de dolor regional complejo 复杂局部疼痛综合征
Pub Date : 2012-01-01 DOI: 10.1016/j.semreu.2011.10.005
Esther Márquez Martínez, M. Victoria Ribera Canudas, Ángela Mesas Idáñez, Javier Medel Rebollo, Pedro Martínez Ripol, Alejandro Candela Custardoy, Marisa Paños Gozalo

Complex regional pain syndrome (CRPS) is a painful disorder, classified in two types depending on whether no nerve lesion has been detected (type I) or whether a nerve lesion is present (type II). CRPS usually develops after a noxious event (trauma injury or surgery), but can sometimes appear spontaneously, and genetic factors may predispose to CRPS. Several etiopathogenic concepts have been proposed, such as neurogenic inflammation, pathological sympathetic activation and neuroplastic changes in the central nervous system. Diagnosis is mainly based on clinical symptoms and signs, such as autonomic, motor and sensory disturbances. The most common and early symptom is pain, as well as distal edema, sweating, disturbances of skin temperature and color, hyperalgesia, motor weakness and, in chronic phases, skin and muscle atrophy. Therapy should be based on a multidisciplinary approach, including non-pharmacological therapies (physiotherapy, occupational therapy, psychological therapy), pharmacological treatments (analgesics, steroids, free radical scavengers, calcitonin, bisphosphonates), and invasive interventions (sympathetic nerve blockade, spinal cord stimulators).

复杂局部疼痛综合征(CRPS)是一种疼痛性疾病,根据是否未发现神经损伤(I型)或是否存在神经损伤(II型)分为两种类型。CRPS通常在有害事件(创伤损伤或手术)后发生,但有时也会自发出现,遗传因素可能使CRPS易感。一些致病概念已被提出,如神经源性炎症、病理性交感神经激活和中枢神经系统的神经可塑性改变。诊断主要基于临床症状和体征,如自主神经、运动和感觉障碍。最常见和早期的症状是疼痛,以及远端水肿、出汗、皮肤温度和颜色紊乱、痛觉过敏、运动无力,在慢性期,皮肤和肌肉萎缩。治疗应以多学科方法为基础,包括非药物治疗(物理治疗、职业治疗、心理治疗)、药物治疗(镇痛药、类固醇、自由基清除剂、降钙素、双膦酸盐)和侵入性干预(交感神经阻断、脊髓刺激)。
{"title":"Síndrome de dolor regional complejo","authors":"Esther Márquez Martínez,&nbsp;M. Victoria Ribera Canudas,&nbsp;Ángela Mesas Idáñez,&nbsp;Javier Medel Rebollo,&nbsp;Pedro Martínez Ripol,&nbsp;Alejandro Candela Custardoy,&nbsp;Marisa Paños Gozalo","doi":"10.1016/j.semreu.2011.10.005","DOIUrl":"10.1016/j.semreu.2011.10.005","url":null,"abstract":"<div><p>Complex regional pain syndrome (CRPS) is a painful disorder, classified in two types depending on whether no nerve lesion has been detected (type I) or whether a nerve lesion is present (type II). CRPS usually develops after a noxious event (trauma injury or surgery), but can sometimes appear spontaneously, and genetic factors may predispose to CRPS. Several etiopathogenic concepts have been proposed, such as neurogenic inflammation, pathological sympathetic activation and neuroplastic changes in the central nervous system. Diagnosis is mainly based on clinical symptoms and signs, such as autonomic, motor and sensory disturbances. The most common and early symptom is pain, as well as distal edema, sweating, disturbances of skin temperature and color, hyperalgesia, motor weakness and, in chronic phases, skin and muscle atrophy. Therapy should be based on a multidisciplinary approach, including non-pharmacological therapies (physiotherapy, occupational therapy, psychological therapy), pharmacological treatments (analgesics, steroids, free radical scavengers, calcitonin, bisphosphonates), and invasive interventions (sympathetic nerve blockade, spinal cord stimulators).</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 1","pages":"Pages 31-36"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.10.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128456105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Formación Médica Continuada 继续医学教育
Pub Date : 2012-01-01 DOI: 10.1016/j.semreu.2012.01.001
{"title":"Formación Médica Continuada","authors":"","doi":"10.1016/j.semreu.2012.01.001","DOIUrl":"https://doi.org/10.1016/j.semreu.2012.01.001","url":null,"abstract":"","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 1","pages":"Pages 37-38"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2012.01.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136937479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nefropatía lúpica silente
Pub Date : 2012-01-01 DOI: 10.1016/j.semreu.2011.10.002
Montserrat M. Díaz Encarnación, José Ballarín Castan

Silent lupus nephritis (SLN) is an unusual clinical presentation of lupus nephritis (LN) and may be an underdiagnosed entity. Renal biopsy is the only diagnostic method but is invasive and is not indicated in asymptomatic patients. Consequently, the prevalence of this disease is difficult to determine. Data from more than 250 SLN cases published in the literature were analyzed from isolated cases, case studies and prospective studies. Of the 226 well-described cases, we selected 197 reported after the 1970s. Patients with class I lesions (n = 29, 15%) were excluded as they fell outside the definition of SLN. Among included patients, there were 107 with class II (54.3), 45 with class III (22.8%), 50 with class IV (25.4%), 9 with class V (4.6%) and one with class VI. Forty percent had proliferative forms (classes III and IV), the most severe forms of LN.

Of the 197 patients, 65 patients (33%) from six publications were followed-up. The data did not allow conclusions to be drawn on the epidemiology or prognosis of this entity. Future studies are required to clarify these issues.

沉默性狼疮性肾炎(SLN)是狼疮性肾炎(LN)的一种不寻常的临床表现,可能是一种未被诊断的实体。肾活检是唯一的诊断方法,但它是侵入性的,不适用于无症状的患者。因此,这种疾病的流行程度很难确定。从孤立病例、案例研究和前瞻性研究中分析了文献中发表的250多例SLN病例的数据。在226例描述良好的病例中,我们选择了1970年代以后报告的197例。I级病变患者(n = 29,15 %)因超出SLN定义而被排除。在纳入的患者中,II类患者107例(54.3),III类患者45例(22.8%),IV类患者50例(25.4%),V类患者9例(4.6%),VI类患者1例。40%的患者为最严重的LN增生型(III类和IV类)。197例患者中,有65例患者(33%)接受了随访。这些数据不能得出关于该疾病流行病学或预后的结论。需要进一步的研究来澄清这些问题。
{"title":"Nefropatía lúpica silente","authors":"Montserrat M. Díaz Encarnación,&nbsp;José Ballarín Castan","doi":"10.1016/j.semreu.2011.10.002","DOIUrl":"10.1016/j.semreu.2011.10.002","url":null,"abstract":"<div><p><span>Silent lupus nephritis<span> (SLN) is an unusual clinical presentation of lupus nephritis (LN) and may be an underdiagnosed entity. Renal biopsy is the only diagnostic method but is invasive and is not indicated in asymptomatic patients. Consequently, the prevalence of this disease is difficult to determine. Data from more than 250 SLN cases published in the literature were analyzed from isolated cases, case studies and prospective studies. Of the 226 well-described cases, we selected 197 reported after the 1970s. Patients with class I lesions (n</span></span> <!-->=<!--> <!-->29, 15%) were excluded as they fell outside the definition of SLN. Among included patients, there were 107 with class II (54.3), 45 with class III (22.8%), 50 with class IV (25.4%), 9 with class V (4.6%) and one with class VI. Forty percent had proliferative forms (classes III and IV), the most severe forms of LN.</p><p>Of the 197 patients, 65 patients (33%) from six publications were followed-up. The data did not allow conclusions to be drawn on the epidemiology or prognosis of this entity. Future studies are required to clarify these issues.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"13 1","pages":"Pages 3-7"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.10.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125676692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tratamiento de la artritis reumatoide del anciano 老年人类风湿性关节炎的治疗
Pub Date : 2011-10-01 DOI: 10.1016/j.semreu.2011.07.001
María Jesús García Arias, Jesús Alberto García Vadillo

In the international literature, rheumatoid arthritis (RA) of the elderly is considered to be that affecting persons aged over 65 years. Currently, this population comprises most series of patients with RA and includes both persons with disease onset after this age and those with chronic RA developing years previously. RA with onset after the age of 65 is called elderly onset rheumatoid arthritis (EORA) and shows slightly different clinical manifestations from RA developing in younger individuals. However, both the therapeutic arsenal used and the objectives proposed for the treatment of RA of the elderly differ little from those employed in younger patients. The same therapies are employed but are adapted to the particular characteristics of this population, such as pharmacokinetic changes, comorbidities, and an increased susceptibility to infection. The aim of treatment —disease remission— is the same as in younger patients. Excessive caution in the use of drugs may lead to suboptimal treatment, especially in the initial stages when the disease is more active, and leave irreversible sequelae. Treatment should be individually tailored to the patient's characteristics, with adequate monitoring. Traditionally, elderly patients more frequently received glucocorticoids and were rarely treated with disease-modifying antirheumatic drugs (DMARDs) or biological agents. People over 65 years are underrepresented in clinical trials but there seem to be no particular contraindications to the use of methotrexate or anti-tumor-necrosis factor (anti-TNF) agents in this population. Data from national registries in several countries have confirmed the similar safety and efficacy of DMARDs and anti-TNF agents in elderly patients. Data on the administration of other biological agents in the elderly are limited. Rheumatologists should be aware of the higher risk of adverse events in this population, especially when using non-steroidal anti-inflammatory drugs, and should recognize the need to adjust treatment to the individual characteristics and comorbidities of each patient.

在国际文献中,老年人类风湿关节炎(RA)被认为是影响65岁以上人群的疾病。目前,这一人群包括大多数系列的RA患者,包括在此年龄之后发病的患者和多年前发展的慢性RA患者。65岁以后发病的类风湿关节炎称为老年发病类风湿性关节炎(EORA),其临床表现与年轻人发病的类风湿关节炎略有不同。然而,老年人类风湿关节炎的治疗方法和目标与年轻患者的治疗方法差别不大。采用相同的治疗方法,但要适应这一人群的特殊特征,如药代动力学变化、合并症和对感染的易感性增加。治疗的目的——疾病缓解——与年轻患者相同。在使用药物时过于谨慎可能导致治疗不理想,特别是在疾病较活跃的初始阶段,并留下不可逆转的后遗症。治疗应根据患者的特点进行个体化调整,并进行充分的监测。传统上,老年患者更多地接受糖皮质激素治疗,很少使用改善疾病的抗风湿药物(DMARDs)或生物制剂。65岁以上的人群在临床试验中代表性不足,但在这一人群中使用甲氨蝶呤或抗肿瘤坏死因子(anti-TNF)药物似乎没有特别的禁忌症。来自几个国家的国家登记处的数据证实,dmard和抗tnf药物在老年患者中具有相似的安全性和有效性。关于老年人使用其他生物制剂的数据有限。风湿病学家应该意识到这一人群发生不良事件的风险较高,特别是在使用非甾体抗炎药时,并且应该认识到需要根据每个患者的个体特征和合并症调整治疗。
{"title":"Tratamiento de la artritis reumatoide del anciano","authors":"María Jesús García Arias,&nbsp;Jesús Alberto García Vadillo","doi":"10.1016/j.semreu.2011.07.001","DOIUrl":"10.1016/j.semreu.2011.07.001","url":null,"abstract":"<div><p>In the international literature, rheumatoid arthritis (RA) of the elderly is considered to be that affecting persons aged over 65 years. Currently, this population comprises most series of patients with RA and includes both persons with disease onset after this age and those with chronic RA developing years previously. RA with onset after the age of 65 is called elderly onset rheumatoid arthritis (EORA) and shows slightly different clinical manifestations from RA developing in younger individuals. However, both the therapeutic arsenal used and the objectives proposed for the treatment of RA of the elderly differ little from those employed in younger patients. The same therapies are employed but are adapted to the particular characteristics of this population, such as pharmacokinetic changes, comorbidities, and an increased susceptibility to infection. The aim of treatment —disease remission— is the same as in younger patients. Excessive caution in the use of drugs may lead to suboptimal treatment, especially in the initial stages when the disease is more active, and leave irreversible sequelae. Treatment should be individually tailored to the patient's characteristics, with adequate monitoring. Traditionally, elderly patients more frequently received glucocorticoids and were rarely treated with disease-modifying antirheumatic drugs (DMARDs) or biological agents. People over 65 years are underrepresented in clinical trials but there seem to be no particular contraindications to the use of methotrexate or anti-tumor-necrosis factor (anti-TNF) agents in this population. Data from national registries in several countries have confirmed the similar safety and efficacy of DMARDs and anti-TNF agents in elderly patients. Data on the administration of other biological agents in the elderly are limited. Rheumatologists should be aware of the higher risk of adverse events in this population, especially when using non-steroidal anti-inflammatory drugs, and should recognize the need to adjust treatment to the individual characteristics and comorbidities of each patient.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"12 4","pages":"Pages 103-107"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116767871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Gardfield, Hirsch y el signo de los tiempos 加德菲尔德,赫希和时代的标志
Pub Date : 2011-10-01 DOI: 10.1016/j.semreu.2011.07.003
Alejandro Olivé
{"title":"Gardfield, Hirsch y el signo de los tiempos","authors":"Alejandro Olivé","doi":"10.1016/j.semreu.2011.07.003","DOIUrl":"10.1016/j.semreu.2011.07.003","url":null,"abstract":"","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"12 4","pages":"Pages 101-102"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129723848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABC de la acupuntura en reumatología 风湿病学中针灸的基本知识
Pub Date : 2011-10-01 DOI: 10.1016/j.semreu.2011.07.002
Juan Muñoz-Ortego , Pedro Marco-Aznar

Acupuncture is a medical procedure and therefore requires a diagnosis, a therapeutic indication and a prognosis. These tasks form part of medical expertise and must be carried out by suitably qualified and accredited health professionals. Recent investigations have started to establish the scientific basis of acupuncture and consequently the mechanisms of action and the local and systemic mediators involved in this modality are beginning to be understood. Published systematic reviews indicate that the main rheumatic diseases the benefit from acupuncture are osteoarthritis, myofascial pain syndrome, epicondylitis, and neck, shoulder and low back pain. From the perspective of evidence-based medicine, the use of acupuncture in the treatment of osteoarthritis and chronic cervical and lumbar pain is efficient in terms of quality-adjusted life years. Accordingly, acupuncture is a strategy that should be considered in excellent healthcare management.

针灸是一种医疗程序,因此需要诊断、治疗指征和预后。这些任务是医学专业知识的一部分,必须由适当合格和认可的保健专业人员执行。最近的研究已经开始建立针灸的科学基础,因此,作用机制和参与这种方式的局部和全身介质开始被理解。已发表的系统综述表明,从针灸获益的主要风湿性疾病是骨关节炎、肌筋膜疼痛综合征、上髁炎以及颈、肩和腰痛。从循证医学的角度来看,针灸治疗骨关节炎和慢性颈腰椎痛在质量调整生命年方面是有效的。因此,针灸是在优秀的医疗管理中应该考虑的策略。
{"title":"ABC de la acupuntura en reumatología","authors":"Juan Muñoz-Ortego ,&nbsp;Pedro Marco-Aznar","doi":"10.1016/j.semreu.2011.07.002","DOIUrl":"10.1016/j.semreu.2011.07.002","url":null,"abstract":"<div><p>Acupuncture is a medical procedure and therefore requires a diagnosis, a therapeutic indication and a prognosis. These tasks form part of medical expertise and must be carried out by suitably qualified and accredited health professionals. Recent investigations have started to establish the scientific basis of acupuncture and consequently the mechanisms of action and the local and systemic mediators involved in this modality are beginning to be understood. Published systematic reviews indicate that the main rheumatic diseases the benefit from acupuncture are osteoarthritis, myofascial pain syndrome, epicondylitis, and neck, shoulder and low back pain. From the perspective of evidence-based medicine, the use of acupuncture in the treatment of osteoarthritis and chronic cervical and lumbar pain is efficient in terms of quality-adjusted life years. Accordingly, acupuncture is a strategy that should be considered in excellent healthcare management.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"12 4","pages":"Pages 108-111"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127862543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Síndrome de Wartenberg 瓦滕贝格综合症
Pub Date : 2011-10-01 DOI: 10.1016/j.semreu.2011.08.001
Gibran Mancheno Abdo , Melania Martinez Morillo , Beatriz Tejera Segura , Alejando Olivé

Wartenberg's syndrome is a rare compression neuropathy of the sensory branch of the radial nerve and is characterized by pain and paresthesia in the radial dorsal forearm radiating to the back of the thumb and second and third fingers. The etiology of this syndrome can be varied. Diagnosis is based on clinical history, physical examination and electromyography. The most common treatment is nonsurgical with splints and steroid injections. The prognosis of Wartenberg's syndrome is usually good. The present article reviews this entity.

Wartenberg综合征是一种罕见的桡神经感觉分支压迫性神经病变,其特征是桡侧前臂背侧放射到拇指和第二、第三指背部的疼痛和感觉异常。这种综合征的病因是多种多样的。诊断依据临床病史、体格检查和肌电图。最常见的治疗是夹板和类固醇注射的非手术治疗。Wartenberg综合征的预后通常很好。本文回顾了这一实体。
{"title":"Síndrome de Wartenberg","authors":"Gibran Mancheno Abdo ,&nbsp;Melania Martinez Morillo ,&nbsp;Beatriz Tejera Segura ,&nbsp;Alejando Olivé","doi":"10.1016/j.semreu.2011.08.001","DOIUrl":"10.1016/j.semreu.2011.08.001","url":null,"abstract":"<div><p>Wartenberg's syndrome is a rare compression neuropathy of the sensory branch of the radial nerve and is characterized by pain and paresthesia in the radial dorsal forearm radiating to the back of the thumb and second and third fingers. The etiology of this syndrome can be varied. Diagnosis is based on clinical history, physical examination and electromyography. The most common treatment is nonsurgical with splints and steroid injections. The prognosis of Wartenberg's syndrome is usually good. The present article reviews this entity.</p></div>","PeriodicalId":101152,"journal":{"name":"Seminarios de la Fundación Espa?ola de Reumatología","volume":"12 4","pages":"Pages 128-130"},"PeriodicalIF":0.0,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.semreu.2011.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134407738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminarios de la Fundación Espa?ola de Reumatología
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1